Head-to-head · WeighScore
Alloy vs Primary Clinic (Direct GLP)
The verdict
Alloy takes it — 72/100 to 68.7/100.
Alloy grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Alloy is a menopause-focused telehealth brand whose Weight Care program runs the broadest GLP-1 formulary in our catalog — brand Wegovy, brand Zepbound, oral Wegovy, plus compounded semaglutide, tirzepatide…
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Alloy | Primary Clinic (Direct GLP) |
|---|---|---|
| WeighScore | 72/100 | 68.7/100 |
| Grade | C | C |
| Scorecard rank | #84 | #145 |
| Semaglutide | $169/mo (compounded) | $65/mo (0.25 mg dose, promotional rate, compounded) |
| Tirzepatide | $199/mo (compounded) | $110/mo (2.5 mg dose, promotional rate, compounded) |
| Coverage | Coverage not published | 10 states |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #84 · C
Strengths
- Broadest GLP-1 formulary here: brand Wegovy and Zepbound, oral Wegovy, plus compounded semaglutide, tirzepatide, and liraglutide
- All consulting doctors are certified by The Menopause Society — a rare credential
- STARTGLP1 promo code takes $50 off the first month
- Spans the price range: compounded semaglutide from $70/mo, brand Wegovy from $199/mo (each plus the $99/mo Weight Care fee)
Where it loses points
- Menopause-focused — best for women in menopause or perimenopause, not men or younger patients
- A mandatory $99/mo Alloy Weight Care fee sits on top of every medication price (so the true minimum is ~$169/mo, not $70)
- Compounded semaglutide not available in AL, AR, CA, NV, LA, MS or DC
Graded #145 · C
Strengths
- Direct Primary Care model integrates GLP-1 with continuous primary care — unlike most direct-to-consumer platforms
- GLP-1 at wholesale cost with no markup — semaglutide from $65/mo, tirzepatide from $110/mo (members only)
- Unlimited primary care visits, direct text access, and same-day care bundled in the $89/mo membership
- Routine labs and thousands of medications included in membership — no surprise bills
- Per-dose pricing shown publicly for all 8 dose tiers of both semaglutide and tirzepatide
Where it loses points
- 10 states only (WA, NM, AZ, UT, FL, DC, KS, OK, VA, GA) — limited vs 50-state platforms
- Membership required to access wholesale pricing — $89/mo adds ~$1,068/yr in fixed cost
- 503A pharmacy partners not named
- LegitScript certification not mentioned on the site
- Medical director and corporate legal entity not disclosed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.